BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37839102)

  • 1. Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse Models.
    Cox KE; Turner MA; Amirfakhri S; Lwin TM; Hosseini M; Ghosh P; Obonyo M; Murakami T; Hoffman RM; Yazaki PJ; Bouvet M
    J Surg Res; 2024 Jan; 293():701-708. PubMed ID: 37839102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models.
    Turner MA; Amirfakhri S; Nishino H; Neel NC; Hosseini M; Cox KE; Lwin TM; Li L; Hong T; Sherman A; Shively JE; Hoffman RM; Yazaki PJ; Bouvet M
    J Surg Res; 2023 Nov; 291():596-602. PubMed ID: 37540977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model.
    DeLong JC; Murakami T; Yazaki PJ; Hoffman RM; Bouvet M
    J Surg Res; 2017 Oct; 218():139-143. PubMed ID: 28985840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
    Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved antibody-guided surgery with a near-infrared dye on a pegylated linker for CEA-positive tumors.
    Yazaki P; Lwin T; Minnix M; Li L; Sherman A; Molnar J; Miller A; Frankel P; Chea J; Poku E; Bowles N; Hoffman R; Shively J; Bouvet M
    J Biomed Opt; 2019 Jun; 24(6):1-9. PubMed ID: 31254333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.
    Lwin TM; Turner MA; Amirfakhri S; Nishino H; Debie P; Cosman BC; Hoffman RM; Hernot S; Bouvet M
    J Surg Oncol; 2021 Dec; 124(7):1121-1127. PubMed ID: 34309885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanized Anti-Tumor-Associated Glycoprotein-72 for Submillimeter Near-Infrared Detection of Colon Cancer in Metastatic Mouse Models.
    Hollandsworth HM; Amirfakhri S; Filemoni F; Hoffman RM; Molnar J; Yazaki PJ; Bouvet M
    J Surg Res; 2020 Aug; 252():16-21. PubMed ID: 32217350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanized Fluorescent Tumor-associated Glycoprotein-72 Antibody Selectively Labels Colon-cancer Liver Metastases in Orthotopic Mouse Models.
    Hollandsworth HM; Nishino H; Turner M; Amirfakhri S; Filemoni F; Hoffman RM; Yazaki PJ; Bouvet M
    In Vivo; 2020; 34(5):2303-2307. PubMed ID: 32871754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules.
    Turner MA; Amirfakhri S; Nishino H; Lwin TM; Savides TJ; Reid TR; Singer BB; Hoffman RM; Bouvet M
    In Vivo; 2021; 35(4):1959-1963. PubMed ID: 34182469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors.
    Baart VM; van Manen L; Bhairosingh SS; Vuijk FA; Iamele L; de Jonge H; Scotti C; Resnati M; Cordfunke RA; Kuppen PJK; Mazar AP; Burggraaf J; Vahrmeijer AL; Sier CFM
    Mol Imaging Biol; 2023 Feb; 25(1):122-132. PubMed ID: 34642899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft.
    Turner MA; Hollandsworth HM; Nishino H; Amirfakhri S; Lwin TM; Lowy AM; Kaur S; Natarajan G; Mallya K; Hoffman RM; Batra SK; Bouvet M
    In Vivo; 2022; 36(1):57-62. PubMed ID: 34972700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
    Metildi CA; Kaushal S; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
    J Surg Oncol; 2014 Apr; 109(5):451-8. PubMed ID: 24249594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
    Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific tumor labeling enhanced by polyethylene glycol linkage of near infrared dyes conjugated to a chimeric anti-carcinoembryonic antigen antibody in a nude mouse model of human pancreatic cancer.
    Maawy AA; Hiroshima Y; Zhang Y; Luiken GA; Hoffman RM; Bouvet M
    J Biomed Opt; 2014; 19(10):101504. PubMed ID: 24887695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.
    Hollandsworth HM; Lwin TM; Amirfakhri S; Filemoni F; Batra SK; Hoffman RM; Dhawan P; Bouvet M
    J Surg Res; 2019 Oct; 242():145-150. PubMed ID: 31077946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer.
    Lwin TM; Hernot S; Hollandsworth H; Amirfakhri S; Filemoni F; Debie P; Hoffman RM; Bouvet M
    Surgery; 2020 Jul; 168(1):85-91. PubMed ID: 32370916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-mucin 4 fluorescent antibody brightly targets colon cancer in patient-derived orthotopic xenograft mouse models: A proof-of-concept study for future clinical applications.
    Turner MA; Hollandsworth HM; Amirfakhri S; Lwin TM; Nishino H; Neel NC; Natarajan G; Kaur S; Mallya K; Hoffman RM; Batra SK; Bouvet M
    Am J Surg; 2022 Oct; 224(4):1081-1085. PubMed ID: 35715267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer.
    Lwin TM; Minnix M; Li L; Sherman A; Hong T; Wong JYC; Olafsen T; Poku E; Bouvet M; Fong Y; Shively JE; Yazaki PJ
    Mol Imaging Biol; 2023 Aug; 25(4):727-734. PubMed ID: 37341873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system.
    Hiroshima Y; Maawy A; Metildi CA; Zhang Y; Uehara F; Miwa S; Yano S; Sato S; Murakami T; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Laparoendosc Adv Surg Tech A; 2014 Apr; 24(4):241-7. PubMed ID: 24494971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.
    Hiroshima Y; Lwin TM; Murakami T; Mawy AA; Kuniya T; Chishima T; Endo I; Clary BM; Hoffman RM; Bouvet M
    J Surg Oncol; 2016 Dec; 114(8):951-958. PubMed ID: 27696448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.